Molecular Identity of Platelet CD40 Ligand (CD40L)

Thromb Haemost 2001; 86(02): 718
DOI: 10.1055/s-0037-1616113

Letters to the Editor

Schattauer GmbH

Artur-Aron Weber

¹Institut für Pharmakologie und Klinische Pharmakologie, Düsseldorf, Germany

,

Alexander Hermann

¹Institut für Pharmakologie und Klinische Pharmakologie, Düsseldorf, Germany

,

Bernhard H Rauch

¹Institut für Pharmakologie und Klinische Pharmakologie, Düsseldorf, Germany

,

Karsten Schrör

¹Institut für Pharmakologie und Klinische Pharmakologie, Düsseldorf, Germany

References
1 Mach F, Schönbeck U, Libby P. CD40 signaling in vascular cells: A key role in atherosclerosis?. Atherosclerosis 1998; 137 (Suppl.) S89-S95.
2 Graf D, Müller S, Korthäuer U, van Kooten C, Weise C, Kroczek RA. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 1995; 25: 1749-54.
3 Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
4 Hermann A, Rauch BH, Braun M, Schrör K, Weber A-A. Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001; 12: 74-82.
5 Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Froland SS, Gullestad L. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100: 614-20.